BIIB
Biogen Inc.Company with tickers: BIIB
CIK
875045
CUSIP
09062X103
Shares Outstanding
147,637,117
13F Activity (30d)
690 filings
655 filers
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-01 | Keeney Adam |
Head of Corporate Development | Convert | 939 |
| 2026-05-01 | Keeney Adam |
Head of Corporate Development | Tax | 455 |
| 2026-05-01 | Keeney Adam |
Head of Corporate Development | Convert | 939 |
| 2026-04-01 | Godbout Sean |
Chief Accounting Officer | Convert | 181 |
| 2026-04-01 | Godbout Sean |
Chief Accounting Officer | Tax | 54 |
| 2026-04-01 | Godbout Sean |
Chief Accounting Officer | Convert | 181 |
| 2026-03-31 | BIOGEN INC. |
10% Owner | Other | 0 |
| 2026-03-31 | BIOGEN INC. |
10% Owner | Other | 0 |
| 2026-03-31 | BIOGEN INC. |
10% Owner | Other | 0 |
| 2026-02-13 | Gregory Ginger |
EVP, Human Resources | Award | 8,025 |
| 2026-02-13 | Kramer Robin |
Chief Financial Officer | Award | 8,450 |
| 2026-02-13 | Grogan Jane |
Head of Research | Award | 8,450 |
| 2026-02-13 | Godbout Sean |
Chief Accounting Officer | Award | 1,800 |
| 2026-02-13 | Izzar Rachid |
Head of Global Product Strat. | Award | 7,390 |
| 2026-02-13 | Murphy Nicole |
Head of Pharm Ops and Tech | Award | 10,560 |
| 2026-02-13 | Keeney Adam |
Head of Corporate Development | Award | 8,025 |
| 2026-02-13 | Singhal Priya |
Head of Development | Award | 10,560 |
| 2026-02-13 | Viehbacher Christopher |
Director, President and CEO | Award | 38,015 |
| 2026-02-13 | ALEXANDER SUSAN H |
EVP Chief Legal Officer | Award | 8,450 |
| 2026-02-12 | Murphy Nicole |
Head of Pharm Ops and Tech | Buy | 3 |
| 2026-02-09 | Singhal Priya |
Head of Development | Sell | 2,660 |
| 2026-02-06 | Grogan Jane |
Head of Research | Tax | 584 |
| 2026-02-06 | Gregory Ginger |
EVP, Human Resources | Convert | 3,746 |
| 2026-02-06 | Godbout Sean |
Chief Accounting Officer | Convert | 305 |
| 2026-02-06 | ALEXANDER SUSAN H |
EVP Chief Legal Officer | Convert | 4,916 |
| 2026-02-06 | Izzar Rachid |
Head of Global Product Strat. | Convert | 3,043 |
| 2026-02-06 | Izzar Rachid |
Head of Global Product Strat. | Convert | 2,044 |
| 2026-02-06 | ALEXANDER SUSAN H |
EVP Chief Legal Officer | Tax | 1,514 |
| 2026-02-06 | ALEXANDER SUSAN H |
EVP Chief Legal Officer | Other | 20,082 |
| 2026-02-06 | Godbout Sean |
Chief Accounting Officer | Convert | 305 |
| 2026-02-06 | Izzar Rachid |
Head of Global Product Strat. | Convert | 3,043 |
| 2026-02-06 | Izzar Rachid |
Head of Global Product Strat. | Convert | 1,802 |
| 2026-02-06 | Murphy Nicole |
Head of Pharm Ops and Tech | Convert | 2,102 |
| 2026-02-06 | Viehbacher Christopher |
Director, President and CEO | Tax | 4,356 |
| 2026-02-06 | Singhal Priya |
Head of Development | Tax | 1,412 |
| 2026-02-06 | Viehbacher Christopher |
Director, President and CEO | Convert | 9,008 |
| 2026-02-06 | Izzar Rachid |
Head of Global Product Strat. | Tax | 775 |
| 2026-02-06 | Gregory Ginger |
EVP, Human Resources | Tax | 1,132 |
| 2026-02-06 | Viehbacher Christopher |
Director, President and CEO | Convert | 15,453 |
| 2026-02-06 | Gregory Ginger |
EVP, Human Resources | Convert | 1,635 |
| 2026-02-06 | Singhal Priya |
Head of Development | Convert | 2,217 |
| 2026-02-06 | Izzar Rachid |
Head of Global Product Strat. | Tax | 805 |
| 2026-02-06 | Viehbacher Christopher |
Director, President and CEO | Tax | 6,624 |
| 2026-02-06 | Grogan Jane |
Head of Research | Convert | 1,385 |
| 2026-02-06 | Murphy Nicole |
Head of Pharm Ops and Tech | Tax | 914 |
| 2026-02-06 | Kramer Robin |
Chief Financial Officer | Tax | 1,063 |
| 2026-02-06 | Godbout Sean |
Chief Accounting Officer | Tax | 76 |
| 2026-02-06 | Grogan Jane |
Head of Research | Convert | 1,873 |
| 2026-02-06 | Murphy Nicole |
Head of Pharm Ops and Tech | Convert | 2,102 |
| 2026-02-06 | Viehbacher Christopher |
Director, President and CEO | Convert | 9,008 |
Showing 1–50 of 999 transactions